It is noteworthy that HIF-1 has been regarded as a therapeutic target for cancer progression, and the level of vascular endothelial growth factor (VEGF), which is a downstream of HIF-1 correlated with tumor weights in a murine model of OSA [16]. The gene discussed is HIF1A; the disease is neoplasm.